VA

Vinu Aduppukoottiya Parambath

Active Director Director DIN 09033055
DIN 09033055 First appointment Jan 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Vinu Aduppukoottiya Parambath

Data last updated:

Vinu Aduppukoottiya Parambath is a Director at Dheyus Pharma Private Limited (since 2021). The company operates in Healthcare.

DIN 09033055
Primary Designation Director
Industry Healthcare
First Appointment 18 Jan 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dheyus Pharma Private Limited U24290KL2021PTC067000
Director18 Jan 20212021Active

Board colleagues of Vinu Aduppukoottiya Parambath

NameDINCompanyDesignation
Abdul Kalam Nadaveliyil Moideenkunjuasan02172926Dheyus Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Dheyus Pharma Private Limited
Premium access

Shareholding and investment profile for Vinu Aduppukoottiya Parambath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vinu Aduppukoottiya Parambath

Vinu Aduppukoottiya Parambath currently holds 1 directorship: Dheyus Pharma Private Limited (Director, since 18 Jan 2021).

Vinu Aduppukoottiya Parambath was first appointed on 18 Jan 2021 as Director at Dheyus Pharma Private Limited.

The current boards of Vinu Aduppukoottiya Parambath's companies include Abdul Kalam Nadaveliyil Moideenkunjuasan (Dheyus Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available